Qymune develops next-generation T cell engager (TCE) platform designed to deliver powerful efficacy with unprecedented safety for patients. Our vision extends beyond oncology to autoimmune and other immune-driven diseases, where precisely removing pathogenic cells has the potential to fundamentally change patients’ lives. By combining deep immunology, antibody engineering, and cutting-edge science, we are reimagining the future of T cell engager therapies - with safety, precision, and durability at the core.

Qymune

Org chart

Teams

Offices